Drug-induced hypersensitivity syndrome and eosinophils in skin biopsy in a patient with pancytopenia.
作者信息
Gallo Marin Benjamin, Ollila Thomas A, Robbins Allison, Brooks Blake E, Firoz Elnaz F, Massoud Cathy M
机构信息
Division of Hematology and Oncology, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Brown Dermatology and Pathology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
出版信息
Am J Hematol. 2023 Apr;98(4):697-699. doi: 10.1002/ajh.26742. Epub 2022 Oct 3.
Abstract
摘要
相似文献
1
Drug-induced hypersensitivity syndrome and eosinophils in skin biopsy in a patient with pancytopenia.
Am J Hematol. 2023 Apr;98(4):697-699. doi: 10.1002/ajh.26742. Epub 2022 Oct 3.
2
Agranulocytosis associated with voriconazole-induced hypersensitivity syndrome.
J Dermatol. 2018 May;45(5):e118-e119. doi: 10.1111/1346-8138.14142. Epub 2017 Nov 23.
3
Drug-induced hypersensitivity syndrome by ethambutol: A case report.
J Dermatol. 2016 Aug;43(8):971-2. doi: 10.1111/1346-8138.13318. Epub 2016 Feb 19.
4
Allopurinol Induced DRESS Syndrome.
J Assoc Physicians India. 2014 Nov;62(11):63-5.
5
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with histologic features mimicking cutaneous pseudolymphoma.
J Dermatol. 2014 Sep;41(9):856-7. doi: 10.1111/1346-8138.12590. Epub 2014 Aug 25.
6
Red herring in returned traveler: drug reaction with eosinophilia and systemic symptom (DRESS) syndrome mimicking sepsis.
J Travel Med. 2014 Nov-Dec;21(6):425-8. doi: 10.1111/jtm.12152. Epub 2014 Aug 28.
7
Drug reaction with eosinophilia and systemic symptoms presenting as leukoencephalopathy.
J Dermatol. 2019 Aug;46(8):e305-e307. doi: 10.1111/1346-8138.14821. Epub 2019 Mar 14.
8
Recurrence of DRESS syndrome to escitalopram or neosensitization?
Therapie. 2019 Sep;74(4):504-506. doi: 10.1016/j.therap.2019.02.005. Epub 2019 Mar 5.
9
Azathioprine hypersensitivity syndrome: report of two cases with cutaneous manifestations.
Clin Exp Dermatol. 2021 Aug;46(6):1097-1101. doi: 10.1111/ced.14643. Epub 2021 Apr 26.
10
Vancomycin-induced drug reactions with eosinophilia and systemic symptoms syndrome in a patient with positive family history.
Dermatol Online J. 2021 Nov 15;27(11). doi: 10.5070/D3271156098.
本文引用的文献
1
The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML.
Leukemia. 2022 Mar;36(3):701-711. doi: 10.1038/s41375-021-01462-4. Epub 2021 Nov 8.
2
Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Int J Mol Sci. 2021 Feb 21;22(4):2147. doi: 10.3390/ijms22042147.
3
Expanding Purpura in a Neutropenic Patient.
JAMA Oncol. 2017 Sep 1;3(9):1276-1277. doi: 10.1001/jamaoncol.2017.0781.
4
Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
Br J Dermatol. 2015 Jul;173(1):50-8. doi: 10.1111/bjd.13683. Epub 2015 Apr 16.
5
Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels.
Cytokine. 2013 Mar;61(3):885-91. doi: 10.1016/j.cyto.2012.12.023. Epub 2013 Jan 26.
6
Sweet syndrome with histiocytoid infiltrate and neutropenia: a rare combination.
J Am Acad Dermatol. 2009 Nov;61(5):882-4. doi: 10.1016/j.jaad.2008.12.038. Epub 2009 Sep 6.
7
Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome.
Br J Dermatol. 1998 Dec;139(6):1026-32. doi: 10.1046/j.1365-2133.1998.02559.x.
8
9
Effects of interleukin-5 on acute myeloid leukemias.
Am J Hematol. 1992 Apr;39(4):269-74. doi: 10.1002/ajh.2830390407.
Zotero 插件